‘Cycling is the new golf’: Gel-Squeezing Cyclists in Lycra Fuel Science in Sport IPO

Gel-Squeezing Cyclists in Lycra Fuel Science in Sport IPO

Science in Sport Ltd. broke away from its parent company, Provexis Plc (PXS), and began trading today after an initial public offering as the maker of nutritional sports gels rides a surge in Britain’s Lycra-clad cyclists.

Provexis, a maker of nutritional additives, spun off the company so SiS could focus on expanding the market for Go brand gels, powders and bars. SiS rose 8 percent to 60.5 pence in London, giving the Windsor, England-based company a market value of about 11.7 million pounds ($18.1 million).More Britons have taken up cycling than any other sport, according to Mintel International, the market research firm where the term Mamil — middle-aged man in Lycra — was coined in 2010. SiS Chief Executive Officer Stephen Moon, a former GlaxoSmithKline Plc (GSK) manager, became a Mamil himself to better understand his customers when he joined the company. He owns two carbon-fiber road bikes, a Legend Giau and a Legend HT9.5.

“What do they say now, ‘Cycling is the new golf’? I don’t care what the phrase is, it’s working for us,” Moon said in an interview yesterday. “We’re in a market that keeps growing.”

Cenkos Securities Plc (CNKS) is running the spinoff and the share sale. Royal DSM NV (DSM), the world’s largest maker of vitamins, holds about 9 percent of SiS, while U.K. venture-capital trust Downing LLP owns 16.7 percent, Moon said. Provexis stockholders received one share of Science in Sport for every 100 shares of Provexis.

Andy Murray

Science in Sport was created by cycling enthusiast Tim Lawson in a kitchen in 1992 and was bought by Provexis two years ago. About 60 percent of sales come from cyclists, though the brand has been raising its profile among other athletes with help from the London Olympics last year and from Wimbledon champion and Go gel user Andy Murray. SiS has also widened its appeal to soccer fans, supplying products to Manchester United Plc (MANU) players, Moon said.

Provexis halved its underlying operating loss for the year ending in March to 1.1 million pounds, helped by an 11 percent sales gain in Science in Sport products to 5.5 million pounds. The products include versions with caffeine, nitrates to increase stamina or choline to help the body derive energy from fat, the company said. SiS gels are sold online, at cycling shops and in grocery chains including Tesco Plc. (TSCO)

The U.K. is just the beginning. The company aims to expand in the U.S. market through online sales next year. The gels will appear in stores in cycling-friendly pockets of the U.S. such as northern California and Boulder, Colorado, by 2015. SiS is in talks with two companies for a potential joint venture in the Asia-Pacific region including Australia, Moon said.

Elite Equipment

A Mamil is a man between 35 and 45 with a family, who might opt for a high-end bike instead of a sports car as he hits middle age, according to Mintel. At an amateur cycling event recently, Moon said he struggled to spot a bike valued at less than 3,000 pounds.

“Everyone wants what the elites use,” he said. That drove a decision in February to sign six-time British Olympic Gold Medal track cyclist Chris Hoy as a brand spokesman. “Mamils know Chris Hoy, they look and see him using our products and that’s huge for us.”

Moon said he has dismissed several potential suitors “poking and prodding” for assets to buy. Instead, he wants to achieve a goal of 20 percent annual sales growth.

“We sat down with our investors and we said, let’s get Science in Sport and push it hard and in three years, let’s see where we are then,” Moon said. “We haven’t had a chance to really grow the business yet.”

To contact the reporter on this story: Trista Kelley in London at tkelley2@bloomberg.net

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment